Orna Therapeutics logo

Orna Therapeutics

Wholly Owned Subsidiary of Eli Lilly and Company

127 employees · est. 2019 · Watertown, United States

VS
ReNAgade Therapeutics logo

ReNAgade Therapeutics

RNA Without Limits

24 employees · est. 2021 · Cambridge, United States

Orna Therapeutics is the older company (2019 vs 2021); Orna Therapeutics is the larger of the two.

Side-by-Side Comparison

Orna Therapeutics ReNAgade Therapeutics
Founded
2019 older 2021
Headquarters
Watertown, United States Cambridge, United States
Employees
127 larger 24
Industry
Biotechnology, Health and Wellness, Pharmaceutical Biotechnology, Health and Wellness
Funding Stage
Corporate Series A
Total Funding
$2.72B $300.00M
Funding Rounds
4 1
Services
Development of circular RNA therapeutics, Implementation of in vivo CAR-T cell therapies, Tailored LNP delivery systems RNA-based therapeutic development, Gene therapy solutions, Pharmaceutical research and innovation
Target Customers
Patients with B cell-driven autoimmune diseases, Patients with oncology-related conditions, Biopharmaceutical partners Healthcare professionals, Medical researchers, Pharmaceutical companies, Biotechnology investors
Taxonomy
RNA Therapeutics, Circular RNA, ORNA Technology, Lipid Nanoparticle Delivery, In Vivo Therapies, Disease Treatment, Protein Expression, Therapeutic Development, Genetic Engineering, Drug Delivery Solutions, Novel Technology RNA Therapeutics, RNA Delivery Platforms, Gene Editing, Gene Insertion, Medicine Development, Novel RNA Technologies, Disease Treatment, RNA Coding, Biomedical Innovation, Therapeutic Research, RNA Medicine, Biopharmaceuticals, Paradigm-shifting Medicine
Website
ornatx.com renagadetx.com
Orna Therapeutics logo

About Orna Therapeutics

Orna Therapeutics, founded in 2019, is a cutting-edge biotechnology company that is redefining the scope of RNA therapeutics. Positioned as "Ahead of the Curve," the company is pioneering a novel circular RNA technology platform known as oRNA®, alongside innovative lipid nanoparticle (LNP) delivery...

ReNAgade Therapeutics logo

About ReNAgade Therapeutics

ReNAgade Therapeutics, founded in 2021 and headquartered in the United States, positions itself at the forefront of biotechnology with its compelling mission encapsulated in its slogan, "RNA Without Limits". The company endeavors to revolutionize RNA medicines by leveraging novel RNA delivery platfo...

We will tell you when either one moves

BounceWatch watches Orna Therapeutics and ReNAgade Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Orna Therapeutics and ReNAgade Therapeutics — by email.

Frequently Asked Questions

Orna Therapeutics — Wholly Owned Subsidiary of Eli Lilly and Company. ReNAgade Therapeutics — RNA Without Limits. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Orna Therapeutics has raised $2.72B while ReNAgade Therapeutics has raised $300.00M.
Orna Therapeutics and ReNAgade Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Orna Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Orna Therapeutics on 9 Jun 2026, and ReNAgade Therapeutics on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes